• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

MLA Notice of Intention to Offer a Rights IssuePRICE SENSITIVE13/10/14
MLA Letter to All Shareholders - Rights Issue13/10/14
MLA Notice of Annual General Meeting03/10/14
MLA Annual Report30/09/14
MLA Appendix 4E - 30 June 2014PRICE SENSITIVE29/08/14
MLA Retirement of Chairman27/08/14
MLA Appendix 3B25/08/14
MLA MLA Appoints Dr Amy Crouch as National Veterinary Manager04/08/14
MLA Quarterly Report - 30 June 201430/07/14
MLA Appendix 4CPRICE SENSITIVE30/07/14
MLA MediVet Successful in out of Court SettlementPRICE SENSITIVE07/07/14
MLA MLA licensed for distribution of nanofiber animal technologyPRICE SENSITIVE03/07/14
MLA Appendix 3Y- Mitchell01/07/14
MLA Appendix 3Y- Mitchell19/06/14
MLAAppendix 3B14/05/14
MLAQuarterly Report & Appendix 4C - March 2014PRICE SENSITIVE30/04/14
MLAAppendix 4D & Half-Yearly ReportPRICE SENSITIVE28/02/14
MLAAppendix 3X - Jeremy Delk28/02/14
MLAAppointment of Jeremy Delk as a Director28/02/14
MLAChange of Share Registry19/02/14
MLAAmended Appendix 3X14/02/14
MLAAmendment to Announcement Dated 13 February 201414/02/14
MLAAppendix 3X - Hancox13/02/14
MLAAppendix 3Z - Donnison13/02/14
MLABoard and Management ChangesPRICE SENSITIVE13/02/14
MLANotice of Initial Substantial Holder11/02/14
MLAQuarterly Report December 2013PRICE SENSITIVE31/01/14
MLAAppendix 4CPRICE SENSITIVE31/01/14
MLAResponse to ASX Price Query LetterPRICE SENSITIVE16/01/14
MLAChange in substantial holding16/12/13
MLABecoming a substantial holder12/12/13
MLABecoming a substantial holder12/12/13
MLABecoming a substantial holder12/12/13
MLABecoming a substantial holder12/12/13
MLABecoming a substantial holder12/12/13
MLAMLA Raises $4 Million To Fast Track GrowthPRICE SENSITIVE10/12/13
MLAAppendix 3B10/12/13
MLAAppendix 3B05/12/13
MLAResults of Annual General Meeting29/11/13
MLAChange of Principal Place of Business22/11/13
MLANotice to Shareholders29/10/13
MLANotice of Annual General Meeting29/10/13
MLAAppendix 4CPRICE SENSITIVE25/10/13
MLAAnnual Report 201330/09/13
MLAMLA signs agreement to acquire MediVetPRICE SENSITIVE24/09/13
MLAAppendix 4EPRICE SENSITIVE30/08/13
MLAAppendix 3Y - Mitchell19/08/13
MLAAppendix 4C - Quarter June 2013PRICE SENSITIVE31/07/13
MLAAmended Results of General Meeting - 15 July 201316/07/13
MLAResults of General Meeting - 15 July 201316/07/13
MLAConsolidation of Shares Proposal - Amended Timetable25/06/13
MLAAmended Appendix 3Y - Donnison20/06/13
MLAInvestor Presentation13/06/13
MLAIndependent Expert's Report12/06/13
MLANotice of General Meeting and Explanatory Memorandum12/06/13
MLAAppendix 3Y11/06/13
MLAAppendix 3Y11/06/13
MLAMLA Announces Acquisition of MedivetPRICE SENSITIVE06/06/13
MLAAmended Appendix 4C30/04/13
MLAAppendix 4CPRICE SENSITIVE30/04/13
MLAMLA Expands OEM AgreementsPRICE SENSITIVE22/04/13
MLAMLA strengthens UK presence with NHS Trust Supply AgreementPRICE SENSITIVE12/03/13
MLAHalf Year ReportPRICE SENSITIVE28/02/13
MLAResponse to ASX Query - Appendix 4CPRICE SENSITIVE12/02/13
MLAAppendix 4CPRICE SENSITIVE30/01/13
ALT +FirstFlow Burette market updatePRICE SENSITIVE15/11/12
MLAResults of Annual General Meeting08/11/12
MLAAppendix 4CPRICE SENSITIVE26/10/12
MLANotice of Annual General Meeting08/10/12
MLA2012 Annual Report and Notice of AGM sent to Shareholders08/10/12
MLAAnnual Report 201228/09/12
MLAAmended Appendix 3X31/08/12
MLAAppendix 4EPRICE SENSITIVE28/08/12
MLAAppendix 4CPRICE SENSITIVE30/07/12
ALT +COMMENCEMENT OF SALES OF TUTA BURETTES WITH MEDIAFLUSH tm03/07/12
MLAAppendix 3Y22/06/12
MLAAppendix 3Y18/06/12
MLAAppendix 3B01/05/12
MLAMLA successfully completes first animal stem cell treatmentPRICE SENSITIVE30/04/12
MLAAppendix 4CPRICE SENSITIVE30/04/12
MLABRR Interview05/04/12
MLAMLA first in Europe to cryogenically freeze stem cellsPRICE SENSITIVE03/04/12
MLAAppendix 4DPRICE SENSITIVE28/02/12
MLAAppendix 4CPRICE SENSITIVE25/01/12
MLAUpdate to independent research report on MLA23/01/12
MLAAppendix 3X10/01/12
MLAAppointment of Chairman10/01/12
MLAAppendix 3Z05/12/11
MLADeath of Chairman of the Company30/11/11
MLAMLA secures over $1.5 million in new supply agreementsPRICE SENSITIVE22/11/11
MLABoardroom Radio Webcast14/11/11
MLAChange of Share Registry11/11/11
MLAResults of Annual General Meeting08/11/11
MLAMLA reports first quarter revenue of $3 million27/10/11
MLAAppendix 4CPRICE SENSITIVE27/10/11
MLAAnnexure to Notice of Annual General Meeting07/10/11
MLANotice of Annual General Meeting07/10/11
MLANotice to Shareholders - Annual Report and AGM07/10/11
MLAShare Trading Policy06/10/11
MLAShare Trading Policy04/10/11
MLA Notice of Intention to Offer a Rights Issue
13/10/14PRICE SENSITIVE
MLA Letter to All Shareholders - Rights Issue
13/10/14
MLA Notice of Annual General Meeting
03/10/14
MLA Annual Report
30/09/14
MLA Appendix 4E - 30 June 2014
29/08/14PRICE SENSITIVE
MLA Retirement of Chairman
27/08/14
MLA Appendix 3B
25/08/14
MLA MLA Appoints Dr Amy Crouch as National Veterinary Manager
04/08/14
MLA Quarterly Report - 30 June 2014
30/07/14
MLA Appendix 4C
30/07/14PRICE SENSITIVE
MLA MediVet Successful in out of Court Settlement
07/07/14PRICE SENSITIVE
MLA MLA licensed for distribution of nanofiber animal technology
03/07/14PRICE SENSITIVE
MLA Appendix 3Y- Mitchell
01/07/14
MLA Appendix 3Y- Mitchell
19/06/14
MLAAppendix 3B
14/05/14
MLAQuarterly Report & Appendix 4C - March 2014
30/04/14PRICE SENSITIVE
MLAAppendix 4D & Half-Yearly Report
28/02/14PRICE SENSITIVE
MLAAppendix 3X - Jeremy Delk
28/02/14
MLAAppointment of Jeremy Delk as a Director
28/02/14
MLAChange of Share Registry
19/02/14
MLAAmended Appendix 3X
14/02/14
MLAAmendment to Announcement Dated 13 February 2014
14/02/14
MLAAppendix 3X - Hancox
13/02/14
MLAAppendix 3Z - Donnison
13/02/14
MLABoard and Management Changes
13/02/14PRICE SENSITIVE
MLANotice of Initial Substantial Holder
11/02/14
MLAQuarterly Report December 2013
31/01/14PRICE SENSITIVE
MLAAppendix 4C
31/01/14PRICE SENSITIVE
MLAResponse to ASX Price Query Letter
16/01/14PRICE SENSITIVE
MLAChange in substantial holding
16/12/13
MLABecoming a substantial holder
12/12/13
MLABecoming a substantial holder
12/12/13
MLABecoming a substantial holder
12/12/13
MLABecoming a substantial holder
12/12/13
MLABecoming a substantial holder
12/12/13
MLAMLA Raises $4 Million To Fast Track Growth
10/12/13PRICE SENSITIVE
MLAAppendix 3B
10/12/13
MLAAppendix 3B
05/12/13
MLAResults of Annual General Meeting
29/11/13
MLAChange of Principal Place of Business
22/11/13
MLANotice to Shareholders
29/10/13
MLANotice of Annual General Meeting
29/10/13
MLAAppendix 4C
25/10/13PRICE SENSITIVE
MLAAnnual Report 2013
30/09/13
MLAMLA signs agreement to acquire MediVet
24/09/13PRICE SENSITIVE
MLAAppendix 4E
30/08/13PRICE SENSITIVE
MLAAppendix 3Y - Mitchell
19/08/13
MLAAppendix 4C - Quarter June 2013
31/07/13PRICE SENSITIVE
MLAAmended Results of General Meeting - 15 July 2013
16/07/13
MLAResults of General Meeting - 15 July 2013
16/07/13
MLAConsolidation of Shares Proposal - Amended Timetable
25/06/13
MLAAmended Appendix 3Y - Donnison
20/06/13
MLAInvestor Presentation
13/06/13
MLAIndependent Expert's Report
12/06/13
MLANotice of General Meeting and Explanatory Memorandum
12/06/13
MLAAppendix 3Y
11/06/13
MLAAppendix 3Y
11/06/13
MLAMLA Announces Acquisition of Medivet
06/06/13PRICE SENSITIVE
MLAAmended Appendix 4C
30/04/13
MLAAppendix 4C
30/04/13PRICE SENSITIVE
MLAMLA Expands OEM Agreements
22/04/13PRICE SENSITIVE
MLAMLA strengthens UK presence with NHS Trust Supply Agreement
12/03/13PRICE SENSITIVE
MLAHalf Year Report
28/02/13PRICE SENSITIVE
MLAResponse to ASX Query - Appendix 4C
12/02/13PRICE SENSITIVE
MLAAppendix 4C
30/01/13PRICE SENSITIVE
ALT +FirstFlow Burette market update
15/11/12PRICE SENSITIVE
MLAResults of Annual General Meeting
08/11/12
MLAAppendix 4C
26/10/12PRICE SENSITIVE
MLANotice of Annual General Meeting
08/10/12
MLA2012 Annual Report and Notice of AGM sent to Shareholders
08/10/12
MLAAnnual Report 2012
28/09/12
MLAAmended Appendix 3X
31/08/12
MLAAppendix 4E
28/08/12PRICE SENSITIVE
MLAAppendix 4C
30/07/12PRICE SENSITIVE
ALT +COMMENCEMENT OF SALES OF TUTA BURETTES WITH MEDIAFLUSH tm
03/07/12
MLAAppendix 3Y
22/06/12
MLAAppendix 3Y
18/06/12
MLAAppendix 3B
01/05/12
MLAMLA successfully completes first animal stem cell treatment
30/04/12PRICE SENSITIVE
MLAAppendix 4C
30/04/12PRICE SENSITIVE
MLABRR Interview
05/04/12
MLAMLA first in Europe to cryogenically freeze stem cells
03/04/12PRICE SENSITIVE
MLAAppendix 4D
28/02/12PRICE SENSITIVE
MLAAppendix 4C
25/01/12PRICE SENSITIVE
MLAUpdate to independent research report on MLA
23/01/12
MLAAppendix 3X
10/01/12
MLAAppointment of Chairman
10/01/12
MLAAppendix 3Z
05/12/11
MLADeath of Chairman of the Company
30/11/11
MLAMLA secures over $1.5 million in new supply agreements
22/11/11PRICE SENSITIVE
MLABoardroom Radio Webcast
14/11/11
MLAChange of Share Registry
11/11/11
MLAResults of Annual General Meeting
08/11/11
MLAMLA reports first quarter revenue of $3 million
27/10/11
MLAAppendix 4C
27/10/11PRICE SENSITIVE
MLAAnnexure to Notice of Annual General Meeting
07/10/11
MLANotice of Annual General Meeting
07/10/11
MLANotice to Shareholders - Annual Report and AGM
07/10/11
MLAShare Trading Policy
06/10/11
MLAShare Trading Policy
04/10/11
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.